nodes	percent_of_prediction	percent_of_DWPC	metapath
Amcinonide—ANXA1—mouth—autistic disorder	0.0457	0.145	CbGeAlD
Amcinonide—ANXA1—eye—autistic disorder	0.0291	0.0924	CbGeAlD
Amcinonide—ANXA1—forebrain—autistic disorder	0.0288	0.0916	CbGeAlD
Amcinonide—ANXA1—telencephalon—autistic disorder	0.0265	0.0842	CbGeAlD
Amcinonide—ANXA1—digestive system—autistic disorder	0.0202	0.0643	CbGeAlD
Amcinonide—NR3C1—hindbrain—autistic disorder	0.0181	0.0575	CbGeAlD
Amcinonide—ANXA1—head—autistic disorder	0.0165	0.0524	CbGeAlD
Amcinonide—ANXA1—nervous system—autistic disorder	0.0156	0.0497	CbGeAlD
Amcinonide—ANXA1—central nervous system—autistic disorder	0.0151	0.0479	CbGeAlD
Amcinonide—ANXA1—cerebellum—autistic disorder	0.0147	0.0468	CbGeAlD
Amcinonide—Fluoxymesterone—PRLR—autistic disorder	0.0145	0.446	CrCbGaD
Amcinonide—ANXA1—brain—autistic disorder	0.012	0.038	CbGeAlD
Amcinonide—NR3C1—brainstem—autistic disorder	0.0104	0.033	CbGeAlD
Amcinonide—NR3C1—eye—autistic disorder	0.0101	0.0321	CbGeAlD
Amcinonide—NR3C1—forebrain—autistic disorder	0.01	0.0318	CbGeAlD
Amcinonide—NR3C1—telencephalon—autistic disorder	0.0092	0.0292	CbGeAlD
Amcinonide—NR3C1—digestive system—autistic disorder	0.00703	0.0223	CbGeAlD
Amcinonide—NR3C1—head—autistic disorder	0.00573	0.0182	CbGeAlD
Amcinonide—NR3C1—nervous system—autistic disorder	0.00543	0.0173	CbGeAlD
Amcinonide—NR3C1—central nervous system—autistic disorder	0.00523	0.0166	CbGeAlD
Amcinonide—NR3C1—cerebellum—autistic disorder	0.00511	0.0162	CbGeAlD
Amcinonide—Fluocinolone Acetonide—PLA2G4A—autistic disorder	0.00483	0.149	CrCbGaD
Amcinonide—NR3C1—brain—autistic disorder	0.00415	0.0132	CbGeAlD
Amcinonide—ANXA1—G alpha (i) signalling events—HTR1B—autistic disorder	0.0033	0.00506	CbGpPWpGaD
Amcinonide—Fluticasone Propionate—PLA2G4A—autistic disorder	0.0033	0.102	CrCbGaD
Amcinonide—ANXA1—GPCR ligand binding—HTR1D—autistic disorder	0.0033	0.00506	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—EGR2—autistic disorder	0.00319	0.00489	CbGpPWpGaD
Amcinonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—AVP—autistic disorder	0.00314	0.00481	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—GRM8—autistic disorder	0.00307	0.0047	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—LEP—autistic disorder	0.00304	0.00466	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (i) signalling events—DRD3—autistic disorder	0.00298	0.00456	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—WNT2—autistic disorder	0.00297	0.00456	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—OPRM1—autistic disorder	0.00296	0.00453	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—HTR3A—autistic disorder	0.00293	0.0045	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—AR—autistic disorder	0.00288	0.00441	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—NOS2—autistic disorder	0.00283	0.00434	CbGpPWpGaD
Amcinonide—NR3C1—Signaling events mediated by HDAC Class II—MEF2C—autistic disorder	0.00281	0.00431	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (q) signalling events—AVP—autistic disorder	0.00272	0.00417	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—AVPR1A—autistic disorder	0.0027	0.00414	CbGpPWpGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—AVP—autistic disorder	0.00268	0.00411	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—MIF—autistic disorder	0.00266	0.00408	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—PRLR—autistic disorder	0.00266	0.00408	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—BDNF—autistic disorder	0.00263	0.00403	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—HTR1B—autistic disorder	0.00263	0.00403	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—OXT—autistic disorder	0.00263	0.00403	CbGpPWpGaD
Amcinonide—NR3C1—Nuclear Receptor transcription pathway—AR—autistic disorder	0.00261	0.004	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—GRM5—autistic disorder	0.00261	0.004	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—TSC2—autistic disorder	0.00255	0.00391	CbGpPWpGaD
Amcinonide—Fludrocortisone—AR—autistic disorder	0.00255	0.0783	CrCbGaD
Amcinonide—NR3C1—Regulation of Androgen receptor activity—AR—autistic disorder	0.00253	0.00388	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—OXTR—autistic disorder	0.00253	0.00387	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—PLA2G4A—autistic disorder	0.00251	0.00385	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—SCT—autistic disorder	0.0025	0.00383	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—IL13—autistic disorder	0.0025	0.00383	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—C4B—autistic disorder	0.0025	0.00382	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—HTR5A—autistic disorder	0.00246	0.00377	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—DRD1—autistic disorder	0.00244	0.00374	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—autistic disorder	0.00243	0.00373	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—IL5—autistic disorder	0.00243	0.00372	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—GABRA1—autistic disorder	0.00239	0.00367	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—ADM—autistic disorder	0.00239	0.00366	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—GABBR1—autistic disorder	0.00239	0.00366	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—DRD3—autistic disorder	0.00237	0.00362	CbGpPWpGaD
Amcinonide—NR3C1—Circadian Clock—AVP—autistic disorder	0.00229	0.0035	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (q) signalling events—HTR2A—autistic disorder	0.00226	0.00347	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—OPRM1—autistic disorder	0.00225	0.00345	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—RORA—autistic disorder	0.00224	0.00343	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—HTR5A—autistic disorder	0.00224	0.00343	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—CHRNA7—autistic disorder	0.00222	0.00341	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—IFNG—autistic disorder	0.00217	0.00333	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL5—autistic disorder	0.00216	0.00331	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—IL5—autistic disorder	0.00214	0.00327	CbGpPWpGaD
Amcinonide—Fluoxymesterone—AR—autistic disorder	0.00211	0.0647	CrCbGaD
Amcinonide—ANXA1—GPCR downstream signaling—GABBR2—autistic disorder	0.00209	0.00321	CbGpPWpGaD
Amcinonide—NR3C1—Circadian Clock—MEF2C—autistic disorder	0.00209	0.00321	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—PTGS2—autistic disorder	0.00208	0.00319	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—GJA1—autistic disorder	0.00205	0.00313	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—autistic disorder	0.00202	0.0031	CbGpPWpGaD
Amcinonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK1—autistic disorder	0.00201	0.00308	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—OXT—autistic disorder	0.002	0.00307	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—HTR1B—autistic disorder	0.002	0.00307	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—RORA—autistic disorder	0.00193	0.00296	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—IL2—autistic disorder	0.00193	0.00296	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—ADRB2—autistic disorder	0.00192	0.00294	CbGpPWpGaD
Amcinonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—autistic disorder	0.00191	0.00292	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—GABBR2—autistic disorder	0.0019	0.00291	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—SLC1A3—autistic disorder	0.00189	0.0029	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—AQP4—autistic disorder	0.00189	0.0029	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—APC—autistic disorder	0.00187	0.00286	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—HTR1D—autistic disorder	0.00187	0.00286	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—PRL—autistic disorder	0.00186	0.00286	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—DRD1—autistic disorder	0.00186	0.00285	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—EGF—autistic disorder	0.00184	0.00283	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AR—autistic disorder	0.00181	0.00277	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—DRD3—autistic disorder	0.0018	0.00276	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—AVP—autistic disorder	0.0018	0.00276	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—BCL2—autistic disorder	0.0018	0.00276	CbGpPWpGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—POMC—autistic disorder	0.00178	0.00273	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—IL10—autistic disorder	0.00177	0.00272	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—CALCA—autistic disorder	0.00174	0.00267	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—GRM8—autistic disorder	0.00174	0.00266	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—IL4—autistic disorder	0.00173	0.00264	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—IGF1—autistic disorder	0.00171	0.00262	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—HTR1D—autistic disorder	0.00169	0.0026	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—TPH2—autistic disorder	0.00169	0.00258	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—PDE4A—autistic disorder	0.00163	0.0025	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—CHRNB2—autistic disorder	0.0016	0.00245	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—autistic disorder	0.00158	0.00242	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—GRM8—autistic disorder	0.00158	0.00241	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—HLA-A—autistic disorder	0.00156	0.00239	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MEF2C—autistic disorder	0.00153	0.00235	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—AVPR1A—autistic disorder	0.00153	0.00234	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—WNT2—autistic disorder	0.00153	0.00234	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—IL4—autistic disorder	0.00152	0.00233	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (i) signalling events—POMC—autistic disorder	0.00151	0.00231	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—HTR2A—autistic disorder	0.0015	0.0023	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—IL13—autistic disorder	0.00149	0.00229	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—BCL2—autistic disorder	0.00149	0.00229	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—PTEN—autistic disorder	0.00149	0.00228	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PDE4A—autistic disorder	0.00148	0.00227	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—MAPK1—autistic disorder	0.00148	0.00226	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—GRM5—autistic disorder	0.00148	0.00226	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—VIP—autistic disorder	0.00148	0.00226	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—ADRB2—autistic disorder	0.00146	0.00224	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—CHRNA4—autistic disorder	0.00145	0.00222	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—TF—autistic disorder	0.00143	0.0022	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—OXTR—autistic disorder	0.00143	0.00219	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—PTGS2—autistic disorder	0.00142	0.00217	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—SCT—autistic disorder	0.00141	0.00217	CbGpPWpGaD
Amcinonide—NR3C1—Circadian Clock—SERPINE1—autistic disorder	0.00139	0.00213	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—AVPR1A—autistic disorder	0.00139	0.00213	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NRP2—autistic disorder	0.00138	0.00211	CbGpPWpGaD
Amcinonide—NR3C1—Transcription factor regulation in adipogenesis—IL6—autistic disorder	0.00137	0.00211	CbGpPWpGaD
Amcinonide—Betamethasone—CYP19A1—autistic disorder	0.00137	0.0422	CrCbGaD
Amcinonide—ANXA1—GPCR ligand binding—AVP—autistic disorder	0.00137	0.0021	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—ADM—autistic disorder	0.00135	0.00207	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—GABBR1—autistic disorder	0.00135	0.00207	CbGpPWpGaD
Amcinonide—NR3C1—Endoderm Differentiation—APC—autistic disorder	0.00135	0.00206	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—SLC6A4—autistic disorder	0.00135	0.00206	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—GRM5—autistic disorder	0.00134	0.00205	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—VIP—autistic disorder	0.00134	0.00205	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HTR5A—autistic disorder	0.00132	0.00202	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—PDE4B—autistic disorder	0.00131	0.00201	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—NTRK2—autistic disorder	0.00131	0.00201	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—IL1RN—autistic disorder	0.00131	0.002	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—OXTR—autistic disorder	0.0013	0.00199	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—SCT—autistic disorder	0.00128	0.00197	CbGpPWpGaD
Amcinonide—Dexamethasone—NOS2—autistic disorder	0.00128	0.0393	CrCbGaD
Amcinonide—ANXA1—GPCR downstream signaling—OPRM1—autistic disorder	0.00127	0.00195	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—PTEN—autistic disorder	0.00124	0.00189	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—GABBR1—autistic disorder	0.00123	0.00188	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—ADM—autistic disorder	0.00123	0.00188	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—MAPK1—autistic disorder	0.00121	0.00186	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—POMC—autistic disorder	0.0012	0.00183	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PDE4B—autistic disorder	0.00119	0.00183	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—OPRM1—autistic disorder	0.00116	0.00177	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—HTR2A—autistic disorder	0.00114	0.00175	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—IL6—autistic disorder	0.00113	0.00174	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—OXT—autistic disorder	0.00113	0.00173	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—HTR1B—autistic disorder	0.00113	0.00173	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GABBR2—autistic disorder	0.00112	0.00172	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—POMC—autistic disorder	0.0011	0.00169	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—GJA1—autistic disorder	0.00108	0.00165	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—AR—autistic disorder	0.00107	0.00164	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—MEF2C—autistic disorder	0.00105	0.00161	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—DRD1—autistic disorder	0.00105	0.00161	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—IFNG—autistic disorder	0.00104	0.0016	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—CARS2—autistic disorder	0.00104	0.00159	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—CARS—autistic disorder	0.00104	0.00159	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—HTR1B—autistic disorder	0.00103	0.00157	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—OXT—autistic disorder	0.00103	0.00157	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—autistic disorder	0.00102	0.00156	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—DRD3—autistic disorder	0.00102	0.00156	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—MAOA—autistic disorder	0.00101	0.00155	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—MAPK1—autistic disorder	0.001	0.00154	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HTR1D—autistic disorder	0.001	0.00153	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—IL5—autistic disorder	0.000997	0.00153	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—AVP—autistic disorder	0.000993	0.00152	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CALCA—autistic disorder	0.000984	0.00151	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—BDNF—autistic disorder	0.000978	0.0015	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PRLR—autistic disorder	0.000964	0.00148	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—DRD1—autistic disorder	0.000955	0.00146	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—IL10—autistic disorder	0.000934	0.00143	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GRM8—autistic disorder	0.000931	0.00143	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—IL2—autistic disorder	0.000927	0.00142	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—DRD3—autistic disorder	0.000924	0.00142	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—IFNG—autistic disorder	0.000919	0.00141	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—autistic disorder	0.000914	0.0014	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—POMC—autistic disorder	0.000911	0.0014	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—MEF2C—autistic disorder	0.000909	0.00139	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—IL5—autistic disorder	0.000905	0.00139	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—WNT2—autistic disorder	0.000901	0.00138	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CALCA—autistic disorder	0.000894	0.00137	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—LEP—autistic disorder	0.000889	0.00136	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GHR—autistic disorder	0.000888	0.00136	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PDE4A—autistic disorder	0.000875	0.00134	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—PTEN—autistic disorder	0.000872	0.00134	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—HTR2A—autistic disorder	0.000827	0.00127	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—ADRB2—autistic disorder	0.000825	0.00126	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—AVPR1A—autistic disorder	0.000819	0.00126	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—RORA—autistic disorder	0.000817	0.00125	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—IL2—autistic disorder	0.000816	0.00125	CbGpPWpGaD
Amcinonide—Dexamethasone—CYP19A1—autistic disorder	0.000799	0.0245	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—VIP—autistic disorder	0.000791	0.00121	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GRM5—autistic disorder	0.000791	0.00121	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—AVP—autistic disorder	0.000775	0.00119	CbGpPWpGaD
Amcinonide—Triamcinolone—PTGS2—autistic disorder	0.000771	0.0237	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—OXTR—autistic disorder	0.000766	0.00117	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—SCT—autistic disorder	0.000759	0.00116	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—ADRB2—autistic disorder	0.000749	0.00115	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—IGF1—autistic disorder	0.000735	0.00113	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—autistic disorder	0.000734	0.00112	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GABBR1—autistic disorder	0.000724	0.00111	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ADM—autistic disorder	0.000724	0.00111	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—EIF4E—autistic disorder	0.000711	0.00109	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PDE4B—autistic disorder	0.000705	0.00108	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—AVP—autistic disorder	0.000704	0.00108	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—autistic disorder	0.000702	0.00108	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—SERPINE1—autistic disorder	0.000698	0.00107	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—OPRM1—autistic disorder	0.000683	0.00105	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PLA2G4A—autistic disorder	0.000662	0.00101	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—HTR2A—autistic disorder	0.000645	0.000988	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—MBD3—autistic disorder	0.000642	0.000984	CbGpPWpGaD
Amcinonide—Betamethasone—PTGS2—autistic disorder	0.000631	0.0194	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—GZMB—autistic disorder	0.000625	0.000957	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—autistic disorder	0.000625	0.000957	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—OXT—autistic disorder	0.000607	0.000929	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HTR1B—autistic disorder	0.000607	0.000929	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—HTR2A—autistic disorder	0.000586	0.000897	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—TAF1C—autistic disorder	0.000578	0.000886	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—PRKCB—autistic disorder	0.000565	0.000866	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TSC1—autistic disorder	0.000564	0.000864	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—DRD1—autistic disorder	0.000564	0.000864	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NTRK2—autistic disorder	0.000549	0.00084	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—DRD3—autistic disorder	0.000546	0.000837	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—IL6—autistic disorder	0.000545	0.000834	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—PIK3CG—autistic disorder	0.000541	0.000829	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IL5—autistic disorder	0.000535	0.000819	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CALCA—autistic disorder	0.000528	0.000809	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—POMC—autistic disorder	0.000515	0.000789	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PRKCB—autistic disorder	0.000513	0.000786	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PIK3CG—autistic disorder	0.000491	0.000753	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—autistic disorder	0.00048	0.000735	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—POMC—autistic disorder	0.000468	0.000716	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PRL—autistic disorder	0.000466	0.000715	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—AR—autistic disorder	0.000451	0.000692	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ADRB2—autistic disorder	0.000442	0.000678	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—AVP—autistic disorder	0.000416	0.000637	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IGF2—autistic disorder	0.000414	0.000634	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—RORA—autistic disorder	0.000394	0.000603	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PLA2G4A—autistic disorder	0.000391	0.000599	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—IL2—autistic disorder	0.000381	0.000583	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MEF2C—autistic disorder	0.00038	0.000582	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ITGB3—autistic disorder	0.000371	0.000568	CbGpPWpGaD
Amcinonide—Dexamethasone—PTGS2—autistic disorder	0.000367	0.0113	CrCbGaD
Amcinonide—NR3C1—Gene Expression—RPL10—autistic disorder	0.000362	0.000554	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HTR2A—autistic disorder	0.000346	0.00053	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—EIF4E—autistic disorder	0.000346	0.00053	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—IL2—autistic disorder	0.000346	0.00053	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—IL6—autistic disorder	0.000332	0.000508	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TSC2—autistic disorder	0.000329	0.000503	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—LEP—autistic disorder	0.000322	0.000493	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—APOE—autistic disorder	0.000322	0.000493	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PRKCB—autistic disorder	0.000303	0.000465	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—APC—autistic disorder	0.00029	0.000445	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PIK3CG—autistic disorder	0.00029	0.000445	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—EGF—autistic disorder	0.000287	0.00044	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—IL6—autistic disorder	0.000287	0.000439	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—POMC—autistic disorder	0.000276	0.000423	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IGF1—autistic disorder	0.000266	0.000407	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—MAPK1—autistic disorder	0.000264	0.000405	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—SERPINE1—autistic disorder	0.000255	0.00039	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—SERPINE1—autistic disorder	0.000252	0.000387	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—AR—autistic disorder	0.000217	0.000333	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—HRAS—autistic disorder	0.000212	0.000325	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IL2—autistic disorder	0.000204	0.000313	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—IL6—autistic disorder	0.000203	0.000311	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PTEN—autistic disorder	0.000192	0.000294	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MAPK1—autistic disorder	0.000156	0.000239	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HRAS—autistic disorder	0.000125	0.000192	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—SERPINE1—autistic disorder	0.000123	0.000188	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IL6—autistic disorder	0.00012	0.000184	CbGpPWpGaD
